Connection

Syed Hasan to Angiotensin Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Syed Hasan has written about Angiotensin Receptor Antagonists.
Syed Hasan
Connection Strength
0.697
Angiotensin Receptor Antagonists
  1. Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Hypertens Res. 2021 08; 44(8):1042-1045.
    View in: PubMed
    Score: 0.278
  2. Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis. Am J Cardiovasc Drugs. 2020 Dec; 20(6):571-590.
    View in: PubMed
    Score: 0.265
  3. Do the Meta-Analyses Provide a Clean Bill of Health to the Use of Renin-angiotensin System Inhibitors in Coronavirus Disease 2019 (COVID-19)? Clin Infect Dis. 2021 07 01; 73(1):164-165.
    View in: PubMed
    Score: 0.070
  4. Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic. Expert Rev Cardiovasc Ther. 2021 01; 19(1):99-100.
    View in: PubMed
    Score: 0.067
  5. Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. J Drug Target. 2020 Aug-Sep; 28(7-8):683-699.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.